Variant report
Variant | esv32772 |
---|---|
Chromosome Location | chr21:16587490-16592163 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:16584216..16586791-chr21:16587079..16588631,2 | MCF-7 | breast: | |
2 | chr21:16421751..16443998-chr21:16557859..16589610,273 | MCF-7 | breast: | |
3 | chr21:16586940..16589372-chr21:16591214..16594501,3 | MCF-7 | breast: | |
4 | chr21:16249191..16252092-chr21:16587437..16590052,2 | MCF-7 | breast: | |
5 | chr21:16584909..16587844-chr21:16591132..16593725,3 | K562 | blood: | |
6 | chr21:16586904..16589804-chr21:16590773..16592275,2 | K562 | blood: | |
7 | chr21:16584909..16587844-chr21:16591132..16593725,3 | K562 | blood: | |
8 | chr21:16586904..16589804-chr21:16590773..16592275,2 | K562 | blood: | |
9 | chr21:16586940..16589372-chr21:16591214..16594501,3 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NRIP1-5 | chr21:16588147-16588197 | NONHSAT081196 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000180530 | chromatin interactions |
ENSG00000236471 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370010085 | chr21:16587533-16587534 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs554499842 | chr21:16587544-16587545 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs567997917 | chr21:16587587-16587588 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs566597978 | chr21:16587590-16587591 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs533880921 | chr21:16587736-16587737 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs536834246 | chr21:16587815-16587816 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs556504651 | chr21:16587817-16587818 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs576055786 | chr21:16587827-16587828 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs544789577 | chr21:16587832-16587833 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs536797154 | chr21:16587843-16587844 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs529349495 | chr21:16587849-16587850 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs146651717 | chr21:16587884-16587885 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs548924023 | chr21:16587897-16587898 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs540667917 | chr21:16587932-16587933 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs140432010 | chr21:16587947-16587948 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs529964323 | chr21:16587948-16587949 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs2823155 | chr21:16587952-16587953 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs372715690 | chr21:16587962-16587963 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs11396786 | chr21:16587974-16587975 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs398121452 | chr21:16587984-16587985 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs144132860 | chr21:16588027-16588028 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs531787988 | chr21:16588031-16588032 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs146497115 | chr21:16588034-16588035 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs140817764 | chr21:16588040-16588041 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs71331710 | chr21:16588056-16588057 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs184716829 | chr21:16588115-16588116 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs527674554 | chr21:16588132-16588133 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs547842134 | chr21:16588201-16588202 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs377685291 | chr21:16588227-16588228 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs567934371 | chr21:16588244-16588245 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs76663894 | chr21:16588249-16588250 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs189909225 | chr21:16588270-16588271 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs538510569 | chr21:16588271-16588272 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs111718187 | chr21:16588282-16588283 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs182540752 | chr21:16588313-16588314 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs13046557 | chr21:16588359-16588360 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs558202052 | chr21:16588366-16588367 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs150231916 | chr21:16588395-16588396 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs373523472 | chr21:16588585-16588586 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs377583837 | chr21:16588663-16588664 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs187060383 | chr21:16588675-16588676 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs2823156 | chr21:16588680-16588681 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs2823157 | chr21:16588690-16588691 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs191126364 | chr21:16588705-16588706 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs180695164 | chr21:16588724-16588725 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs532200571 | chr21:16588749-16588750 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs75657636 | chr21:16588763-16588764 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs185032487 | chr21:16588774-16588775 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs527811227 | chr21:16588836-16588837 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs190283820 | chr21:16588851-16588852 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Epilepsy | 20502679 | CNVD |
22q11.2 microdeletion syndrome | 19750312 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20409316 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:16585400-16587800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr21:16585400-16592000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr21:16585600-16591400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr21:16586000-16591400 | Weak transcription | Primary hematopoietic stem cells | blood |
5 | chr21:16586400-16592400 | Weak transcription | Liver | Liver |
6 | chr21:16586600-16587800 | Weak transcription | HepG2 | liver |
7 | chr21:16587800-16588600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr21:16588600-16591400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr21:16590200-16592200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr21:16591200-16591400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr21:16591200-16592200 | Weak transcription | HepG2 | liver |
12 | chr21:16591400-16592200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr21:16591400-16592200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
14 | chr21:16591400-16592400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr21:16591400-16592400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr21:16591400-16595200 | Enhancers | Primary hematopoietic stem cells | blood |
17 | chr21:16591600-16597400 | Enhancers | Primary monocytes fromperipheralblood | blood |
18 | chr21:16592000-16592200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
19 | chr21:16592000-16592600 | Enhancers | HSMMtube | muscle |
20 | chr21:16592000-16592800 | Weak transcription | Psoas Muscle | Psoas |
21 | chr21:16592000-16596400 | Enhancers | A549 | lung |